iTRAQ-Based Proteomics Analysis of Plasma of Myasthenia Gravis Patients Treated with Jia Wei Bu Zhong Yi Qi Decoction

Figure 2

KEGG analysis of the top 10 upregulated and downregulated pathways in (a) MG patients without treatment (T1) vs. healthy volunteers (C); (b) the group of MG patients with routine western medical treatment (T2) vs. MG patients without treatment (T1); (c) MG patients with combined treatments of Jia Wei BZYQ decoction and routine western medicines (T3) vs. MG patients without treatment (T1); (d) the group of MG patients with combined treatments of Jia Wei BZYQ decoction and routine western medicines (T3) vs. MG patients with routine western medical treatment (T2).

(a)

(b)

(c)

(d)